Literature DB >> 9033388

Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.

K B Lewis1, D C Teller, J Fry, G W Lasser, P D Bishop.   

Abstract

Factor XIII is the terminal enzyme of the coagulation cascade which serves to rapidly crosslink the adjacent gamma-chain C-termini of fibrin clots. In vivo, this process is initiated by the proteolytic action of thrombin which simultaneously converts both soluble fibrinogen to fibrin and activates zymogen FXIII; fibrin then spontaneously polymerizes to form a gel which activated FXIII stabilizes through crosslinking. Due to the kinetic complexity and the difficulty of investigating gel phase reactions, methods employing pre-activation of recombinant human Factor XIII (rFXIII[A'2]) were developed to effectively decouple these reactions. By utilizing these methods, the kinetic parameters of gamma-chain crosslinking in fibrin gels could be determined by both initial rate and integrated rate techniques under physiologically relevant conditions. The crosslinking of the gamma-chain of fibrin gels could be described by apparent Michaelis kinetics with K(m)(app) = 6.2 microM, kcat = 1872 min-1, and Ksp = 302 min-1 microM-1 for a fibrin gamma-chain monomer of M(r) = 170000 Da. In contrast, both the crosslinking rates of alpha-chains within fibrin gels (Ksp = 0.38 min-1 microM-1: Bishop et al. (1993)) and the crosslinking of a soluble synthetic peptide containing the unique gamma-chain fibrin crosslinking site (Ksp = 0.030 min-1 microM-1) could not be shown to saturate and gave apparent first-order rates with respect to rFXIII[A'2]. These observations coupled with the large differences in the turnover rates (approximately 10(4)) suggest two likely mechanisms for FXIII[A'2]-substrate interactions: (1) random (or independent) binding of non- or weakly interacting substrate pairs imposes a high entropic barrier (i. e., delta Gbinding) to the formation of a productive catalytic complex, e.g., for soluble gamma-chain peptides and the flexible alpha-chains within fibrin, and (2) binding to an oriented substrate pair effectively lowers the entropic barrier to formation of a Michaelis complex and thus greatly enhances the rate of catalysis, e.g., for gamma-chain pairs within the fibrin fibrils.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033388     DOI: 10.1021/bi961636z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Leeor S Yefet; James R Byrnes; Laura Ho; Ju Hun Yeon; Sam Filipenko; Alisa S Wolberg; Wilfred A Jefferies; Christian J Kastrup
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  A Facile Two-Step Enzymatic Approach for Conjugating Proteins to Polysaccharide Chitosan at an Electrode Interface.

Authors:  Narendranath Bhokisham; Yi Liu; Haig Pakhchanian; Gregory F Payne; William E Bentley
Journal:  Cell Mol Bioeng       Date:  2016-11-14       Impact factor: 2.321

Review 3.  Biofabricating Functional Soft Matter Using Protein Engineering to Enable Enzymatic Assembly.

Authors:  Yi Liu; Hsuan-Chen Wu; Narendranath Bhokisham; Jinyang Li; Kai-Lin Hong; David N Quan; Chen-Yu Tsao; William E Bentley; Gregory F Payne
Journal:  Bioconjug Chem       Date:  2018-05-16       Impact factor: 4.774

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.